Long- and Short-range Electrostatic Interactions Affect the Rheology of Highly Concentrated Antibody Solutions

Overview

Journal Pharm Res

Specialties Pharmacology
Pharmacy

Date 2009 Oct 2

PMID 19795191

Citations 44

Authors

Ravi Chari

Kavita Jerath

Advait V Badkar

Devendra S Kalonia

Affiliations

Soon will be listed here.

Abstract

Purpose: To explain the differences in protein-protein interactions (PPI) of concentrated versus dilute formulations of a model antibody.

Methods: High frequency rheological measurements from pH 3.0 to 12.0 quantitated viscoelasticity and PPI at high concentrations. Dynamic light scattering (DLS) characterized PPI in dilute solutions.

Results: For concentrated solutions at low ionic strength, the storage modulus, a viscosity component and a measure of PPI, is highest at the isoelectric point (pH 9.0) and lowest at pH 5.4. This profile flattens at higher ionic strength but not completely, indicating PPI consist of long-range electrostatics and other short-range attractions. At low concentrations, PPI are near zero at pI but become repulsive as the pH is shifted. Higher salt concentrations completely flatten this profile to zero, indicating that these PPI are mainly electrostatic.

Conclusions: This discrepancy occurs because long-range interactions are significant at low concentrations, whereas both long- and short-range interactions are significant at higher concentrations. Computer modeling was used to calculate antibody properties responsible for long- and short-range interactions, i.e. net charge and dipole moment. Charge-charge interactions are repulsive while dipole-dipole interactions are attractive. Their net effect correlated with the storage modulus profile. However, only charge-charge repulsions correlated with PPI determined by DLS.

Citing Articles

Design, Synthesis, and Biological Evaluation of Darunavir Analogs as HIV-1 Protease Inhibitors.

Ur Rehman M, Chuntakaruk H, Amphan S, Suroengrit A, Hengphasatporn K, Shigeta Y ACS Bio Med Chem Au. 2024; 4(5):242-256.

PMID: 39431267 PMC: 11487539. DOI: 10.1021/acsbiomedchemau.4c00040.

Portable Microfluidic Viscometer for Formulation Development and in Situ Quality Control of Protein and Antibody Solutions.

Lenzen P, Dingfelder F, Muller M, Arosio P Anal Chem. 2024; 96(32):13185-13190.

PMID: 39093923 PMC: 11325293. DOI: 10.1021/acs.analchem.4c02099.

Molecular surface descriptors to predict antibody developability: sensitivity to parameters, structure models, and conformational sampling.

Park E, Izadi S MAbs. 2024; 16(1):2362788.

PMID: 38853585 PMC: 11168226. DOI: 10.1080/19420862.2024.2362788.

FMO-guided design of darunavir analogs as HIV-1 protease inhibitors.

Chuntakaruk H, Hengphasatporn K, Shigeta Y, Aonbangkhen C, Lee V, Khotavivattana T Sci Rep. 2024; 14(1):3639.

PMID: 38351065 PMC: 10864397. DOI: 10.1038/s41598-024-53940-1.

Variable domain mutational analysis to probe the molecular mechanisms of high viscosity of an IgG antibody.

Dai J, Izadi S, Zarzar J, Wu P, Oh A, Carter P MAbs. 2024; 16(1):2304282.

PMID: 38269489 PMC: 10813588. DOI: 10.1080/19420862.2024.2304282.

References

Buxbaum J, Chuba J, Hellman G, Solomon A, Gallo G . Monoclonal immunoglobulin deposition disease: light chain and light and heavy chain deposition diseases and their relation to light chain amyloidosis. Clinical features, immunopathology, and molecular analysis. Ann Intern Med. 1990; 112(6):455-64. DOI: 10.7326/0003-4819-76-3-112-6-455. View

Wang W, Singh S, Zeng D, King K, Nema S . Antibody structure, instability, and formulation. J Pharm Sci. 2006; 96(1):1-26. DOI: 10.1002/jps.20727. View

Humphrey W, Dalke A, Schulten K . VMD: visual molecular dynamics. J Mol Graph. 1996; 14(1):33-8, 27-8. DOI: 10.1016/0263-7855(96)00018-5. View

Chen W, Huang J, Gilson M . Identification of symmetries in molecules and complexes. J Chem Inf Comput Sci. 2004; 44(4):1301-13. DOI: 10.1021/ci049966a. View

Dolinsky T, Nielsen J, McCammon J, Baker N . PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations. Nucleic Acids Res. 2004; 32(Web Server issue):W665-7. PMC: 441519. DOI: 10.1093/nar/gkh381. View

George A, Chiang Y, Guo B, Arabshahi A, Cai Z, Wilson W . [6] Second virial coefficient as predictor in protein crystal growth. Methods Enzymol. 1997; 276:100-110. DOI: 10.1016/S0076-6879(97)76052-X. View

Saluja A, Badkar A, Zeng D, Nema S, Kalonia D . Ultrasonic storage modulus as a novel parameter for analyzing protein-protein interactions in high protein concentration solutions: correlation with static and dynamic light scattering measurements. Biophys J. 2006; 92(1):234-44. PMC: 1697864. DOI: 10.1529/biophysj.106.095174. View

Papp E, Fricsovszky G, Meszena G . Electrodichroism of purple membrane: ionic strength dependence. Biophys J. 2009; 49(5):1089-100. PMC: 1329689. DOI: 10.1016/S0006-3495(86)83737-7. View

Ganeval D, Noel L, PreudHomme J, Droz D, Grunfeld J . Light-chain deposition disease: its relation with AL-type amyloidosis. Kidney Int. 1984; 26(1):1-9. DOI: 10.1038/ki.1984.126. View

10.

Saluja A, Kalonia D . Application of ultrasonic shear rheometer to characterize rheological properties of high protein concentration solutions at microliter volume. J Pharm Sci. 2005; 94(6):1161-8. DOI: 10.1002/jps.20342. View

11.

Zimmerman S, Minton A . Macromolecular crowding: biochemical, biophysical, and physiological consequences. Annu Rev Biophys Biomol Struct. 1993; 22:27-65. DOI: 10.1146/annurev.bb.22.060193.000331. View

12.

Neal B, Asthagiri D, Lenhoff A . Molecular origins of osmotic second virial coefficients of proteins. Biophys J. 1998; 75(5):2469-77. PMC: 1299921. DOI: 10.1016/S0006-3495(98)77691-X. View

13.

Fulton A . How crowded is the cytoplasm?. Cell. 1982; 30(2):345-7. DOI: 10.1016/0092-8674(82)90231-8. View

14.

Li H, Robertson A, Jensen J . Very fast empirical prediction and rationalization of protein pKa values. Proteins. 2005; 61(4):704-21. DOI: 10.1002/prot.20660. View

15.

Regnier F, White J, Hem S . Contribution of electrostatic and hydrophobic interactions to the adsorption of proteins by aluminium-containing adjuvants. Vaccine. 1995; 13(1):41-4. DOI: 10.1016/0264-410x(95)80009-3. View

16.

Kanai S, Liu J, Patapoff T, Shire S . Reversible self-association of a concentrated monoclonal antibody solution mediated by Fab-Fab interaction that impacts solution viscosity. J Pharm Sci. 2008; 97(10):4219-27. DOI: 10.1002/jps.21322. View

17.

Harper J, Lansbury Jr P . Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu Rev Biochem. 1997; 66:385-407. DOI: 10.1146/annurev.biochem.66.1.385. View

18.

Harris L, Larson S, Hasel K, McPherson A . Refined structure of an intact IgG2a monoclonal antibody. Biochemistry. 1997; 36(7):1581-97. DOI: 10.1021/bi962514+. View

19.

Shaw K, Grimsley G, Yakovlev G, Makarov A, Pace C . The effect of net charge on the solubility, activity, and stability of ribonuclease Sa. Protein Sci. 2001; 10(6):1206-15. PMC: 2374010. DOI: 10.1110/ps.440101. View

20.

Saluja A, Kalonia D . Nature and consequences of protein-protein interactions in high protein concentration solutions. Int J Pharm. 2008; 358(1-2):1-15. DOI: 10.1016/j.ijpharm.2008.03.041. View